NECTIN1 and glioblastoma: Friedman et al also showed that both CD133+ and CD133− GBM cells are targetable by oHSV, and that expression of CD111 (nectin-1), an HSV entry receptor, is an important factor determining sensitivity to oHSV (Friedman et al., 2009).